The Latest Headlines at American Banking and Market News
Charles R. Schwab Sells 65,360 Shares of The Charles Schwab Co. (NYSE:SCHW) Stock
The Charles Schwab Co. (NYSE:SCHW – Get Free Report) Chairman Charles R. Schwab sold 65,360 shares of Charles Schwab stock in a transaction on Tuesday, May 14th. The stock was sold at an average price of $76.89, for a total value... More of this article »
Sheryl Palmer Sells 100,000 Shares of Taylor Morrison Home Co. (NYSE:TMHC) Stock
Taylor Morrison Home Co. (NYSE:TMHC – Get Free Report) CEO Sheryl Palmer sold 100,000 shares of Taylor Morrison Home stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $61.70, for a total... More of this article »
Abeona Therapeutics (NASDAQ:ABEO) Price Target Cut to $21.00
Abeona Therapeutics (NASDAQ:ABEO – Get Free Report) had its target price dropped by Cantor Fitzgerald from $28.00 to $21.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm presently... More of this article »
Ford Motor to Post Q3 2024 Earnings of $0.47 Per Share, Zacks Research Forecasts (NYSE:F)
Ford Motor (NYSE:F – Free Report) – Stock analysts at Zacks Research raised their Q3 2024 EPS estimates for shares of Ford Motor in a report released on Wednesday, May 15th. Zacks Research analyst R. Singhi now anticipates... More of this article »
Needham & Company LLC Reiterates “Buy” Rating for ACV Auctions (NASDAQ:ACVA)
ACV Auctions (NASDAQ:ACVA – Get Free Report)‘s stock had its “buy” rating reiterated by Needham & Company LLC in a note issued to investors on Thursday, Benzinga reports. They presently have a $23.00 target... More of this article »
Natixis Advisors L.P. Grows Position in Marcus & Millichap, Inc. (NYSE:MMI)
Natixis Advisors L.P. grew its stake in Marcus & Millichap, Inc. (NYSE:MMI – Free Report) by 5.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission.... More of this article »
Natixis Advisors L.P. Acquires 13,203 Shares of Healthpeak Properties, Inc. (NYSE:DOC)
Natixis Advisors L.P. boosted its holdings in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 31.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 55,395 shares... More of this article »
Seacoast Banking Co. of Florida (NASDAQ:SBCF) Stock Position Lifted by Natixis Advisors L.P.
Natixis Advisors L.P. grew its position in Seacoast Banking Co. of Florida (NASDAQ:SBCF – Free Report) by 12.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The... More of this article »
Natixis Advisors L.P. Raises Position in Enovis Co. (NYSE:ENOV)
Natixis Advisors L.P. boosted its holdings in shares of Enovis Co. (NYSE:ENOV – Free Report) by 11.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 13,115 shares of the company’s... More of this article »
13,031 Shares in Avantis Emerging Markets Equity ETF (NYSEARCA:AVEM) Purchased by Natixis Advisors L.P.
Natixis Advisors L.P. bought a new stake in shares of Avantis Emerging Markets Equity ETF (NYSEARCA:AVEM – Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 13,031 shares... More of this article »
Natixis Advisors L.P. Has $737,000 Stake in Imperial Oil Limited (NYSEAMERICAN:IMO)
Natixis Advisors L.P. increased its position in Imperial Oil Limited (NYSEAMERICAN:IMO – Free Report) (TSE:IMO) by 3.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,894... More of this article »-logo-1200x675.gif&w=240&h=220&zc=2){kind=logo}
First BanCorp. (NYSE:FBP) Shares Sold by Natixis Advisors L.P.
Natixis Advisors L.P. reduced its stake in shares of First BanCorp. (NYSE:FBP – Free Report) by 10.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional... More of this article »
Natixis Advisors L.P. Increases Holdings in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
Natixis Advisors L.P. raised its stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 10.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange... More of this article »